Sanofi SA
Company Profile
Business description
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Contact
46, avenue de la Grande Armée
Paris 75017
FRAT: +33 153774000
E: investor.relations@sanofi.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
87,994
Sanofi SA News & Analysis
markets
Globalisation declining? Not in investor portfolios
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,104.40 | 45.70 | -0.56% |
| CAC 40 | 8,188.49 | 51.50 | -0.63% |
| DAX 40 | 18,738.81 | 130.55 | -0.69% |
| Dow JONES (US) | 39,869.38 | 38.62 | -0.10% |
| FTSE 100 | 8,438.65 | 7.15 | -0.08% |
| HKSE | 19,403.80 | 27.27 | 0.14% |
| NASDAQ | 16,698.32 | 44.07 | -0.26% |
| Nikkei 225 | 38,782.08 | 138.18 | -0.36% |
| NZX 50 Index | 11,670.99 | 57.07 | -0.49% |
| S&P 500 | 5,297.10 | 11.05 | -0.21% |
| S&P/ASX 200 | 7,834.40 | 46.90 | -0.60% |
| SSE Composite Index | 3,119.82 | 2.58 | -0.08% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.05 | 0.00 | 4.17% |
| Imugene Ltd IMU | 0.08 | 0.00 | 5.63% |
| Pantoro Ltd PNR | 0.09 | 0.01 | 5.75% |
| Strike Energy Ltd STX | 0.21 | 0.01 | -5.56% |
| Pilbara Minerals Ltd PLS | 4.12 | 0.11 | 2.62% |
| Core Lithium Ltd CXO | 0.16 | 0.01 | 3.23% |
| Telstra Group Ltd TLS | 3.69 | 0.01 | -0.14% |
| South32 Ltd S32 | 3.77 | 0.02 | 0.40% |
| Latin Resources Ltd LRS | 0.25 | 0.02 | 8.70% |
| Lake Resources NL LKE | 0.07 | 0.00 | 4.69% |